Thank you very much, Madam Chair.
Because of the fact that we're going to lose a couple of the really important witnesses here, I'm going to try to change my questions somewhat so that maybe we can get some answers later, as they could send these answers to the chair.
Dr. Nemer, you mentioned how behavioural scientists were part of the mix as far as advisers are concerned. Behavioural scientists basically look at how people are going to respond to things such as lockdowns and so on, whereas it's the mental health people who I think are really important in this issue. As the last speaker just mentioned, we have lost so much faith, and we have seen so many drastic things happening in the last number of months that I think, really, we have to be concerned about it.
We talk about international counterparts. Last week we were at 38th, and we are now 58th as far as vaccine deployment is concerned, yet we continually hear how things are just going very well. Well, they aren't going very well.
The other aspect that comes into the science discussion is, why are we not fast-tracking vaccines that have already been approved in the United Kingdom or the U.S. We talk about having to wait for Health Canada to do their due diligence. We speak about how this is an international dilemma. How are we going to manage that?